June 28, 2022

NIH Funds UAMS Study Testing Rapid Genomic Surveillance for Antibiotic Resistant Infections

David Robinson

Se-Ran Jun, Ph.D., discusses her TRI pilot award-supported findings with Fred Prior, Ph.D., distinguished professor and chair of the Department of Biomedical Informatics, at TRI Research Day in April.

A University of Arkansas for Medical Sciences (UAMS) study is developing real-time and accurate genomic methods that can be used routinely to deliver life-saving information to doctors treating antibiotic-resistant infections. Backed by a two-year, $418,000 National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) grant, UAMS’ Se-Ran Jun, Ph.D., says the…


June 27, 2022

UAMS’ Eric Peterson, Ph.D., Named Executive Vice President of BioVentures LLC

David Robinson

Eric Peterson, Ph.D.

LITTLE ROCK — Eric Peterson, Ph.D., has been named executive vice president of BioVentures LLC at the University of Arkansas for Medical Sciences (UAMS). Peterson is chair of the UAMS Patent and Copyright Committee and is an associate professor in the College of Medicine Department of Pharmacology and Toxicology. As executive vice president, he will…


June 7, 2022

UAMS, CAVHS Studying Health Effects of Arkansas Veterans’ Exposure to Burn Pits in Middle East

David Robinson

U.S. Marines with 1st Marine Logistics Group view burn pit at Al Taqaddum Air Base, Iraq, Sept. 22, 2008.

LITTLE ROCK — More than 300 Arkansas veterans will become part of a new study conducted by the University of Arkansas for Medical Sciences (UAMS) and the Central Arkansas Veterans Healthcare System (CAVHS) to determine if exposure to open pit burning and molecular-level changes are associated with chronic health conditions. The Department of Veterans Affairs…


June 2, 2022

UAMS Study First to Test When Common Arsenic Exposures Are Most Likely to Cause Male Infertility in Offspring

David Robinson

Shuk-Mei Ho, Ph.D., and Yuet-Kin "Ricky" Leung, Ph.D., are leading the five-year, $2.54 million arsenic study.

LITTLE ROCK — In the first study of its kind, researchers at the University of Arkansas for Medical Sciences (UAMS) will test when exposure to inorganic arsenic —  a common, harmful environmental toxin — is most likely to lead to infertility traits that may last for generations. The study, supported by a five-year, $2.54 million…


May 31, 2022

TRI Announces Nine KL2 Scholars for 2022-2023

David Robinson

A medical doctor touching the electronic medical record on a tablet.

The UAMS Translational Research Institute’s KL2 Mentored Research Career Development Scholars Program announced nine new scholars for 2022-2023, its largest-ever class. These promising early-career researchers receive two years of funded support and mentored translational research training. The program selects scholars through a competitive application process and provides 75% salary support and up to $25,000 a…


May 26, 2022

Four UAMS Faculty Receive 2022 Provost’s Innovator Awards

David Robinson

The awardees are Lisa Brents, Ph.D., Lyle Burdine, M.D., Ph.D., Craig Forrest, Ph.D., and Gresham Richter, M.D.

The University of Arkansas for Medical Sciences (UAMS) announced four UAMS faculty as recipients of the Provost’s Innovator Awards. The awards were established by Stephanie Gardner, Pharm.D., Ed.D., UAMS provost and chief strategy officer, and Shuk-Mei Ho, Ph.D., vice chancellor for Research and Innovation. The grants of $25,000 each support groundbreaking, innovative, high-impact projects that…


May 23, 2022

UAMS Begins Final Study of First Rapid Test for Acetaminophen Toxicity with $3.2 Million Grant

David Robinson

Laura James, M.D., hopes the final phase of research will lead to FDA approval of the rapid test for acetaminophen toxicity.

The first rapid diagnostic test for acetaminophen toxicity has cleared a major hurdle on its long road to the marketplace from UAMS.


May 20, 2022

ARresearch Study Participants Celebrated on Clinical Trials Day

David Robinson

Nathaniel Noble, an ARresearch volunteer, discusses a study with UAMS' Giuseppina “Giusy” Dusio, Ph.D., in this file photo.

As part of international Clinical Trials Day 2022, research leaders saluted the more than 8,400 Arkansas volunteers in the ARresearch registry at UAMS.


April 28, 2022

UAMS’ Kevin Sexton, M.D., Named BioVentures President

David Robinson

Kevin Sexton, M.D., has been named president of BioVentures LLC, based at the University of Arkansas for Medical Sciences (UAMS).

LITTLE ROCK — Kevin Sexton, M.D., a surgeon and entrepreneur, has been named president of BioVentures LLC, the technology licensing office and business incubator based at the University of Arkansas for Medical Sciences (UAMS). Sexton, an associate professor in the College of Medicine Department of Surgery, became interim director in 2021 following the death of…


April 27, 2022

UAMS Testing New Noninvasive Device for Diagnosing Fetal Heart Conditions

David Robinson

UAMS researcher Hari Eswaran, Ph.D., first will test the new optically-pumped magnetometer's effectiveness detecting fetal heart conditions. The noninvasive imaging technology will be tested in the future for its ability to reveal other important functional details of fetal development.

LITTLE ROCK — Three grants in six months from the National Institutes of Health (NIH) are helping University of Arkansas for Medical Sciences (UAMS) researcher Hari Eswaran, Ph.D., explore promising noninvasive methods for diagnosing serious fetal health conditions. The grants total $4.4 million and support his pioneering work with sensor arrays that can reveal important…



Next page